Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added site revision tag Revision: v3.4.2. Removed the prior government funding lapse notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T02:23:41.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide maintenance notice about funding and the NIH Clinical Center's operating status is displayed, and the page revision has been updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T01:21:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T00:17:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. This appears to be a minor update to the page version with no changes to study details or availability.
    Difference
    0.0%
    Check dated 2026-01-14T01:39:54.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section consolidated into a single multi-state/cross-border list of study sites (CA, FL, GA, IL, MD, MA, MN, MO, NY, TN, TX, WA, Ontario) with revision 3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:23:27.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed; no changes to core study content such as eligibility criteria, endpoints, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:25:33.000Z thumbnail image

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.